Medicare utilization — MARGARITA ROSA GARCES (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 26,460 | 22 | $0 | $210,632 |
| J0897 | Injection, denosumab, 1 mg | 8,100 | 79 | $0 | $149,702 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,505 | 121 | $0 | $1,265 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 656 | 332 | $0 | $65,090 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 289 | 108 | $0 | $16,603 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·